Most patients need to continue treatment indefinitely to maintain weight loss
"The commercial market has grown faster than the clinical evidence base," the paper read, and "the absence of adequate clinical evidence for use in humans is an alarming safety concern." Rita Jew, the ISMP president, told AFP "there's no new information that will make us feel comfortable" that the seven peptides should be authorizied for compounding
The extreme potency, active at concentrations millions of times lower than most compounds, suggests highly specific receptor interactions
the drugs are powerful additions, not replacements
It is worth noting that both metformin and Rybelsus can potentially yield similar side effects, such as nausea, vomiting, diarrhea, belly pain, constipation, upset stomach, and gas